Zoledronate inhibits phosphate and bone morphogenetic protein 2-induced extracellular calcification of vascular smooth muscle cells in vitro

Hu,M.L.; Huang,Y.; Zheng,Z.H.; Lei,Y.; Liu,R.J.; Wang,X.H.; Lindholm,B.; Yu,X.Q.

doi:10.3892/etm.2012.501

Zoledronate inhibits phosphate and bone morphogenetic protein 2-induced extracellular calcification of vascular smooth muscle cells in vitro

Authors:
- M.L. Hu
- Y. Huang
- Z.H. Zheng
- Y. Lei
- R.J. Liu
- X.H. Wang
- B. Lindholm
- X.Q. Yu
View Affiliations

Affiliations: Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University and Key Laboratory of Nephrology, Ministry of Health, Guangzhou, P.R. China, Department of Clinical Science, Intervention and Technology, Karolinska Institute, Stockholm, Sweden
Published online on: March 1, 2012 https://doi.org/10.3892/etm.2012.501
Pages: 841-844

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to explore the effects of the bisphosphonate zoledronate on calcification induced by inorganic phosphate (Pi) and/or bone morphogenetic protein 2 (BMP-2) and the underlying mechanisms. Primary vascular smooth muscle cells (VSMCs) from rats were treated with 3 mM Pi or 3 mM Pi/BMP-2, with and without addition of zoledronate; 1.4 mM Pi served as a control. Calcium deposits, expression of core binding factor α-1 (Cbfa-1), osteopontin (OPN), parathyroid pituitary-specific transcription factor (Pit)-1 and Pit-2, and Pi uptake of VSMCs was determined. The calcification of VSMCs induced by elevated Pi or Pi/BMP-2 was significantly inhibited by zoledronate. The expression of Cbfa-1, OPN and Pit-1 was increased significantly after treatment with an elevated level of Pi or Pi/BMP-2, and this expression was significantly suppressed by addition of zoledronate. Pi uptake of VSMCs increased following treatment with elevated Pi and significantly decreased by addition of zoledronate. These results indicated that zoledronate effectively inhibited calcification induced by Pi/BMP-2, and this may have been achieved by means of the downregulation of expression of calcification-related proteins and uptake of Pi.

View Figures

View References

1.	Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, et al: Vascular Calcification Work Group: vascular calcification in chronic kidney disease. Am J Kidney Dis. 43:572–579. 2004. View Article : Google Scholar : PubMed/NCBI
2.	Jono S, Shioi A, Ikari Y and Nishizawa Y: Vascular calcification in chronic kidney disease. J Bone Miner Metab. 24:176–181. 2006. View Article : Google Scholar
3.	Farzaneh-Far A and Shanahan CM: Biology of vascular calcification in renal disease. Nephron Exp Nephrol. 101:134–138. 2005. View Article : Google Scholar
4.	Giachelli CM: Mechanisms of vascular calcification in uremia. Semin Nephrol. 24:401–402. 2004. View Article : Google Scholar : PubMed/NCBI
5.	Yao Y, Shahbazian A and Bostrom KI: Proline and gamma-carboxylated glutamate residues in matrix Gla protein are critical for binding of bone morphogenetic protein-4. Circ Res. 102:1065–1074. 2008. View Article : Google Scholar : PubMed/NCBI
6.	Shroff RC and Shanahan CM: The vascular biology of calcification. Semin Dial. 20:103–109. 2007.PubMed/NCBI
7.	Li X, Yang HY and Giachelli CM: BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis. 199:271–277. 2008. View Article : Google Scholar : PubMed/NCBI
8.	Hruska KA, Mathew S and Saab G: Bone morphogenetic proteins in vascular calcification. Circ Res. 97:105–114. 2005. View Article : Google Scholar : PubMed/NCBI
9.	Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int. 75:890–897. 2009. View Article : Google Scholar : PubMed/NCBI
10.	Coxon FP, Thompson K and Rogers MJ: Recent advances in understanding the mechanism of action of bisphosphonates. Curr Opin Pharmacol. 6:307–312. 2006. View Article : Google Scholar : PubMed/NCBI
11.	Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L and Hruska KA: The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol. 19:1092–1095. 2008. View Article : Google Scholar : PubMed/NCBI
12.	Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, et al: Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann NY Acad Sci. 1117:209–217. 2007. View Article : Google Scholar : PubMed/NCBI
13.	Persy V, De Broe M and Ketteler M: Bisphosphonates prevent experimental vascular calcification: treat the bone to cure the vessels? Kidney Int. 70:1537–1538. 2006. View Article : Google Scholar : PubMed/NCBI
14.	Price PA, Roublick AM and Williamson MK: Artery calcification in uremic rats is increased by a low protein diet and prevented by treatment with ibandronate. Kidney Int. 70:1577–1583. 2006. View Article : Google Scholar : PubMed/NCBI
15.	Zebboudj AF, Shin V and Bostrom K: Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem. 90:756–765. 2003. View Article : Google Scholar : PubMed/NCBI
16.	Trion A and van der Laarse A: Vascular smooth muscle cells and calcification in atherosclerosis. Am Heart J. 147:808–814. 2004. View Article : Google Scholar : PubMed/NCBI
17.	Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P and Aebersold R, Schinke T, Karsenty G, Giachelli CM and Aebersold R: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 89:1147–1154. 2001. View Article : Google Scholar : PubMed/NCBI
18.	Li X and Giachelli CM: Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens. 16:325–328. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Villa-Bellosta R, Bogaert YE, Levi M and Sorribas V: Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification. Arterioscler Thromb Vasc Biol. 27:1030–1036. 2007. View Article : Google Scholar : PubMed/NCBI
20.	Koshiyama H: Antiatherogenic actions of etidronate on atherosclerosis. Clin Calcium. 12:378–382. 2002.PubMed/NCBI